Navigation Links
OncoGenex Reports Third Quarter Financial Results
Date:11/10/2008

-------------------

Net income (loss) 4,577 (1,930) 752 (6,313)

Redeemable convertible

preferred share accretion 417 735 1,973 2,156

------------------- -------------------

Income (loss) attributable to

common shareholders $ 4,160 $ (2,665) $ (1,221) $ (8,469)

------------------- -------------------

------------------- -------------------

Condensed Balance Sheets

(in thousands)

September 30, December 31,

2008 2007

(unaudited)

Assets:

Cash, cash equivalents and short

term investments $ 17,178 $ 5,131

Amounts and investment tax credit

receivable 1,375 1,813

Prepaid and other current assets 1,129 295

Property, equipment and other assets 566 111

----------------------------

Total assets $ 20,248 $ 7,350

----------------------------

----------------------------

Liabilities and stockholders' equity:

Accounts payable and accrued expenses $ 2,700 $ 1,048

Other current liabilities 905 4,665

Long term liabilities 1,163 2,487

Redeemable convertible preferred shares - 37,373

Stockh
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
2. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
3. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
4. OncoGenex increases economic interest in lead cancer drug OGX-011
5. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
8. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
9. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013  Continuing its long ... infarction (MI), Beckman Coulter , Inc. announces the ... its new Access AccuTnI+3 troponin I assay for use ... "Clinicians have depended on Beckman Coulter,s troponin ... AccuTnI+3 assay has the proven performance to continue providing ...
(Date:6/19/2013)... Atlanta (PRWEB) June 19, 2013 Today ... urged young people to become leaders in the greatest ... 9 billion people in 2050. Borel spoke at ... Conference in Atlanta, about urgent need for students ... that are local, science-based, sustainable and reached in collaboration ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 BioConvergence ... the speaking faculty at 2013’s BioLogistics Summit in ... conference, coordinated by Cold Chain IQ and IQPC, ... This “complexity” is, in part, attributed to current ... , “Implicit within these trends is an increase ...
(Date:6/19/2013)... A new look at “big glass” and ... will highlight technical sessions at SPIE Photomask Technology ... 33rd year, the three-day event is the industry’s largest ... approximately 100 technical presentations and numerous networking lunches and ... optics and photonics , the meeting will be held ...
Breaking Biology Technology:Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3DuPont Leader Calls for New Generation of Food Visionaries to Fight Hunger 2BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3
... significant boost to ... ... attract,multi-million dollar business development projects is being recognized by,Area Development magazine, ... Shovel is awarded to states that have generated,top job-creation and capital ...
... Houston based pest control and animal removal company, is happy to ... the pest management industry. The special designation, awarded by the National ... has taken to ensure their customers, satisfaction. , ... ...
... researchers from Dartmouth,s Thayer School of Engineering and Mascoma ... is important for producing large quantities of cellulosic ethanol, ... to petroleum-derived transportation fuel. For the first time, the ... able to grow at high temperatures, and this new ...
Cached Biology Technology:Ohio Recognized as National Leader for Business Development and Job Creation 2Ohio Recognized as National Leader for Business Development and Job Creation 3Advanced Pest Control Earns Quality Pro Designation for General Pest Control Services 2Advanced Pest Control Earns Quality Pro Designation for General Pest Control Services 3Dartmouth researchers advance cellulosic ethanol production 2
(Date:6/19/2013)... journal Polar Biology, researchers report using DNA from tissues samples ... type of killer whale ( Orcinus orca ). ... on a New Zealand beach and a skeleton was saved ... it was almost 50 years before this unique form of ... bulbous forehead, was documented alive in the wild. , ...
(Date:6/19/2013)... Insulin is the most potent physiological anabolic ... storage and synthesis of lipids, protein and carbohydrates, ... circulatory system. It also plays a major role ... the glucose is metabolized and removed from the ... the precise molecular mechanisms by which insulin regulates ...
(Date:6/19/2013)... are expected to contribute to a very large and ... to a University of Michigan ecologist and colleagues who ... the Chesapeake Bay. , The Gulf forecast, one of ... calls for an oxygen-depleted, or hypoxic, region of between ... among the 10 largest on record. , The low ...
Breaking Biology News(10 mins):Breakthrough research of essential molecule reveals important targets in diabetes and obesity 2U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 2U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 3U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 4
... accurate test to find undetected landmines. Students from the ... green when it comes into contact with chemicals leaked by ... colourless solution that, when sprayed on to the ground, forms ... Researchers say that the organism, which is cheap to produce, ...
... In the largest, most comprehensive genetic analysis of ... has identified five new gene regions, including one involved ... inflammation of the digestive tract that characterizes the disease. ... Hakon Hakonarson, M.D., Ph.D., director of the Center for ...
... Poor Texas. First it was killer bees, then fire ants. ... The invasion of this new species of ants has scientists intrigued, businesses ... entomologist at Sam Houston State University., Cook and other scientists are ... rapacious ant, which is named after exterminator Tom Rasberry, who discovered the ...
Cached Biology News:Largest gene study of childhood IBD identifies 5 new genes 2Rapacious Rasberry ants march north 2
MAb to Desmoplakin I & II Desmoplakin I & II...
Chicken Anti-Human DNA-directed RNA Polymerase II 7.6 Kd Polypeptide (POLR2L Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
...
The BD CBA Human Apoptosis Kit can be used to quantitatively measure,cleaved PARP, Bcl-2, and active Caspase-3 protein levels in a single sample. The,Kit performance has been optimized for analysis o...
Biology Products: